The future of TKIs in cancer treatment is promising, with ongoing research focused on developing new TKIs, overcoming resistance, and improving the efficacy and safety of existing drugs. Personalized medicine approaches, which tailor treatment based on the genetic profile of the patient's tumor, are also being explored to enhance the effectiveness of TKIs.
